Article
Genetic Polymorphism of NOS2 -954G/C in Nasal Polyposis. A case Control Study in a Population Group of Northern Romania
Search Medline for
Authors
Published: | March 26, 2015 |
---|
Outline
Text
Background: Polymorphisms for genes encoding chemosensitive signalling proteins like NOS2, might contribute to the variability in individual susceptibility to nasal polyposis. NO produced by the inducible NO synthase enzyme NOS2A is generated at high levels in certain types of inflammation, so that the role of NOS2 might be important in nasal polyposis etiopathogeny.
Study Design: This is a cross-sectional, randomized, case control study for the evaluation of the frequency of -954G/C NOS2 polymorphism alleles among patients with nasal polyposis.
Subjects: The study included 92 cases of nasal polyposis diagnosed patients (nasal endoscopy and CT scan examination), and 107 healthy unrelated controls.
Methods: -954G/C NOS2 genotyping was carried out using PCR amplification of relevant gene fragment was followed by restriction enzyme digestion. Detection of the variant alleles was determined through analysis of resulting restriction fragment length polymorphism (RFLP) followed by gel electrophoresis.
Results: Molecular analysis revealed an increased frequency of -954G/CNOS2 variant allele in the study group compared to the control group (p=0.043; OR= 1.77; CI=1.02-3.09).
Conclusions: The main finding of our study is that mutant genotype of -954G/C NOS2 is considered to be a risk factor for nasal polyposis development.
Der Erstautor gibt keinen Interessenkonflikt an.